Encephalopathy syndrome in children with hemato‐oncological disorders is not always posterior and reversible
- 25 July 2008
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (5) , 629-633
Abstract
Background: Posterior reversible leukoencephalopathy (PRES) is a clinical‐radiological event that can affect children undergoing chemotherapy regimen. Studies have shown that it is not always reversible, in spite of its original definition. We analyzed PRES cases which occurred during the last 10 years at our institute to focus on their clinical, radiological and EEG follow‐up.Procedures: We analyzed 12 cases of PRES in children who underwent intensive chemotherapy regimens, detailing the acute neurological presentation of the syndrome, their neuro‐imaging characteristics (MRI) and EEG findings, in both an acute phase and during follow‐up.Results: All patients survived the acute event, showing a clinical recovery of the acute neurological signs in 1–3 days and normalization of the EEG pattern in a period ranging from 1 to 8 months. During long term follow‐up, four patients developed either clinical impairment or EEG‐MRI anomalies.Conclusions: We suggest that a long term follow‐up is necessary to determine the reversibility of the neurological events. Clinical observation, as well as EEG and MRI should be included in follow‐up evaluations. Pediatr Blood Cancer 2008;51:629–633.Keywords
This publication has 20 references indexed in Scilit:
- A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantationPediatric Blood & Cancer, 2005
- Posterior reversible encephalopathy syndrome in children with cancerPediatric Blood & Cancer, 2005
- Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocolsLeukemia, 2005
- Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosisBone Marrow Transplantation, 2004
- Clinical findings and magnetic resonance imaging in severe cyclosporine‐related neurotoxicity after allogeneic bone marrow transplantationEuropean Journal of Haematology, 2001
- Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cellsBone Marrow Transplantation, 2000
- FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantationBone Marrow Transplantation, 2000
- Posterior leukoencephalopathy syndrome may not be reversiblePediatric Neurology, 1999
- Occipital-parietal encephalopathy: A new name for an old syndromePediatric Neurology, 1997
- A Reversible Posterior Leukoencephalopathy SyndromeNew England Journal of Medicine, 1996